HERALD OF MEDICINE

Developing a Safety Risk Warning and Classification Framework for Chinese Patent Medicines Containing Toxic Components:A Case Study on Aconitum Ingredients

CHANG Xingjie, GUO Hongye, QI Mingyue, SHI Fanyu, JIN Rui

Herald of Medicine, 2026, 45(1): 76-83. DOI: 10.3870/j.issn.1004-0781.2026.01.011

工艺	草乌		川乌		附子		剂型品种数/个					药品总数^①
工艺	药品数/个	%	药品数/个	%	药品数/个	%	丸剂	片剂	胶囊剂	颗粒剂	口服液	药品数/个	%
水煎煮	5	8.62	4	6.90	12	20.69	1	5	6	3	1	16	27.59
乙醇提取	1	1.72	1	1.72	3	5.17	1	1	1	0	0	3	5.17
原粉入药	17	29.31	9	15.52	22	37.93	24	9	5	1	0	39	67.24

Tab.2 Statistics on the preparation processes of aconite-based Chinese patent medicines

Other figure/table from this article

Tab.1 Distribution of dosage forms of aconite-based Chinese patent medicines
Tab.3 Statistical table of daily dosage of aconitum herbs
Tab.4 Reports on adverse reactions of aconite-based Chinese patent medicines
Tab.5 Analysis of the compatibility structures of traditional Chinese patent medicines containing aconite
Fig.1 Tonification and purgation relationship of pungent Chinese medicine in “Tangye Jingfa map”
Tab.6 Risk assessment scale for aconite-based Chinese patent medicines
Tab.7 Risk warning and classification management of aconite-based Chinese patent medicines